Prognostic Value of the Measurable Residual Disease (MRD) in AML Treatment with Venetoclax in Combination with Hypomethylating Agents: Validation of the ELN 2021 MRD Recommendations Carlos Jimenez-Vicente , Aina Cardus , Guillermo Ramil López , Guadalupe Onate , Iago Arribas , Sara Garcia-Avila , Lucia Gomez-Perez , Daniel Esteban , Antonella Sturla , Francesca Guijarro , Mònica López-Guerra , Sandra Castaño-Díez , Alexandra Martínez-Roca , Albert Cortés-Bullich , Amanda Isabel Perez , Ines Zugasti , Inés Monge-Escartin , Jorge Sierra , Susana Vives , Helena Pomares , Montserrat Arnan , Josep Nomdedeu , Ana Garrido , Marta Pratcorona , Marina Díaz-Beyá , Jordi Esteve Blood（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
